Drug-induced hypersensitivity syndrome课件 28页PPT文档
别嘌呤醇致Stevens-Johnson综合征及中毒性表皮坏死松解症的发病机制和治疗

别嘌呤醇致Stevens-Johnson综合征及中毒性表皮坏死松解症的发病机制和治疗张育云【摘要】别嘌呤醇是次黄嘌呤的同分异构体,在体内可抑制黄嘌呤氧化酶而抑制体内尿酸合成,是目前临床广泛使用的唯一一个抑制尿酸合成的抗痛风药,其可诱发Stevens-Johnson综合征和中毒性表皮坏死松解症。
SJS/TEN虽较为少见,却是危及生命的严重皮肤不良反应。
因此对于SJS/TEN发病机制的认识,可以有效预防SJS/TEN的发生,而正确治疗措施的采取将减少并发症的发生,降低病死率。
本文就SJS/TEN的发病机制及治疗进行综述。
%Allopurinol was an isomer of hypoxanthine, and could inhibit uric acid synthesis by inhibiting xanthinoxidase in vivo. Allopurinol was the only antipodagric which inhibit uric acid synthesis, it currently widely used in clinical and may be induced Stevens-Johnsonsyndrome(SJS) and toxic epidermal necrolysis(TEN).SJS/TEN were rare but life-threatening severe cutaneous adverse reactions (SCARs). So understanding of the pathogenesis for SJS/TEN could be effective in preventing the occurrence of SJS/TEN, and adopt correct therapeutic measure would reduce the incidence of complications and reduce mortality. In this review we summarized the pathogenesis and treatment of SJS/TEN.【期刊名称】《中国医药指南》【年(卷),期】2013(000)009【总页数】4页(P63-65,66)【关键词】别嘌呤醇;Stevens-Johnson综合征;中毒性表皮坏死松解症;发病机制;治疗【作者】张育云【作者单位】蕲春县人民医院药剂科,湖北黄岗 436300【正文语种】中文【中图分类】R758.25别嘌呤醇是黄嘌呤氧化酶抑制剂,它是通过抑制该酶的活性,减少次黄嘌呤、黄嘌呤合成尿酸,从而降低血尿酸水平。
DRESS研究进展

DRESS研究进展陈平姣;李常兴;徐晓;曾抗;张锡宝【摘要】伴嗜酸性粒细胞增多和系统症状的药疹(DRESS),也被称为药物介导的迟发性多器官超敏反应综合征(DIDMOHS)、药物介导的超敏反应综合征(DIHS),是一种具有潜在致命性的药物超敏反应,其特征为皮疹、发烧、淋巴结肿大、血液异常、内脏表现.抗惊厥药,如卡马西平、苯妥英钠、拉莫三嗪、苯巴比妥,以及别嘌呤醇与磺胺类,则是最常见的DRESS诱因.药物解毒作用受损和疱疹病毒激活在DRESS发病中起着关键作用.单倍型人类白细胞抗原(HLA)也发挥作用.早期皮肤表现一般包括麻疹爆发,其特点为弥漫性红斑性瘙痒斑,遍及面部、上部躯干、上肢,后期延及下肢.其特征是快速的融合与进展.DRESS常常涉及淋巴、血液、肝系统.肾、肺、心脏功能障碍可能也会受到牵连.【期刊名称】《皮肤性病诊疗学杂志》【年(卷),期】2017(024)005【总页数】4页(P356-359)【关键词】伴嗜酸性粒细胞增多和系统症状的药疹;发病机制;治疗【作者】陈平姣;李常兴;徐晓;曾抗;张锡宝【作者单位】南方医科大学南方医院皮肤科,广东广州510515;东莞市第六人民医院,广东东莞523008;广州市皮肤病防治所,广东广州510095;南方医科大学南方医院皮肤科,广东广州510515;广州市皮肤病防治所,广东广州510095【正文语种】中文【中图分类】R758.25伴嗜酸性粒细胞增多和系统症状的药疹(drug reaction with eosinophilia and systemic symptoms,DRESS),又称为药物介导的超敏反应综合征(drug-induced hypersensitivity syndrome,DIHS)、药物介导的迟发性多器官超敏反应综合征(drug-induced delayed multi-organ hypersensitivity syndrome,DIDMOHS),是一种具有潜在致命性的药物超敏反应,其特征为皮疹、发烧、淋巴结肿大、血液异常、内脏表现。
[医学]药物超敏反应综合征
![[医学]药物超敏反应综合征](https://img.taocdn.com/s3/m/f62c134ab7360b4c2f3f642a.png)
Etiopathogenesis
Drug:deficiency or abnormality of the epoxide hydroxylase enzyme(环氧酶羟化酶) that detoxifies the metabolites of aromaticamine anticonvulsants (metabolic pathway)
Herpesvirus:associated sequential reactivation of herpesvirus family.(Recently,accumulating evidence suggests that other HHVs, such as HSV, EBV, HHV-7 and CMV might be reactivated during the course of DIHS)
in addition to anticonvulsants,diaphenylsulfone(DDS).
allopurinol(别嘌醇),salazosulfapyridine(柳氮磺胺吡啶) and dapsone(氨苯砜) can also cause DIHS
Defition
Drug-Induced Hypersensitivity Syndrome (DIHS) is a severe and rare systemic reaction triggered by a drug (usually an antiepileptic drug).
药物超敏反应综合征发病机制及治疗的研究进展

2、免疫抑制剂
2、免疫抑制剂
免疫抑制剂在DIHS的治疗中发挥着重要作用。这些药物可以抑制免疫反应, 减轻炎症反应,缓解过敏症状。常用的免疫抑制剂包括环磷酰胺、甲氨蝶呤、糖 皮质激素等。根据病情轻重和患者身体状况,免疫抑制剂的使用量和持续时间可 能有所不同。
3、生物制剂
3、生物制剂
生物制剂是近年来新兴的治疗DIHS的方法。生物制剂是一种针对特定细胞因 子或免疫分子的单克隆抗体,可以针对性地抑制免疫反应或炎症反应。例如,针 对IFN-γ和TNF-α等细胞因子的生物制剂已经在临床试验中显示出治疗DIHS的潜 力。
二、慢性咽炎的药物治疗进展
二、慢性咽炎的药物治疗进展
1、局部治疗局部药物治疗是慢性咽炎治疗的重要手段之一。目前,临床上多 采用消炎、收敛、润喉等药物进行治疗。然而,这些药物往往只能缓解症状,难 以根治疾病。此外,部分药物还可能存在副作用,如激素类药物可能导致免疫力 下降。
二、慢性咽炎的药物治疗进展
4、血浆置换疗法
4、血浆置换疗法
血浆置换疗法是一种通过置换患者血浆中的异常免疫成分来缓解DIHS的方法。 这种疗法可以清除患者血浆中的致病抗体和细胞因子,从而减轻过敏症状。然而, 血浆置换疗法的使用尚处于研究阶段,其长期疗效和安全性还需进一步评估。
5、疫苗调节免疫反应
5、疫苗调节免疫反应
疫苗调节免疫反应是一种新兴的治疗DIHS的方法。通过疫苗接种的方式,诱 导机体产生针对致敏药物的特异性抗体,从而降低再次接触药物的过敏风险。目 前,针对一些常见致敏药物的疫苗已经进入临床试验阶段。
2、T细胞活化与细胞因子
在DIHS的发病过程中,T细胞的活化和细胞因子的产生扮演着关键角色。一些 研究表明,特定的细胞因子,如干扰素-γ(IFN-γ)和肿瘤坏死因子-α(TNFα),在DIHS患者的血清中显著升高。这些细胞因子可以促进炎症反应,导致皮 肤损伤、发热和淋巴结肿大等症状。
药 疹(drug eruption)

2.非变态反应 (drug eruption of noallergy)
发病机制有
❖ ① 药理作用:免疫效应途径的非免疫活化: 某些药物可直接诱导肥大细胞脱颗粒释放组胺 引起荨麻疹。如烟酸可引起血管扩张、面部潮 红,抗凝药可引起紫癜。 阿司匹林可诱导肥 大细胞脱颗粒释放组胺引起荨麻疹。
❖ ②过量反应与蓄积作用:
②可用0.1%肾上腺素0.5ml~1ml肌注,以减轻呼吸道粘膜水 肿及平滑肌痉挛,并可升高血压;亦可加入50%葡萄糖溶 液40ml内静注;
③可先用地塞米松5mg~10mg肌注或静注,然后,可将氢化 可的松200mg~400mg加入5%~10%葡萄糖溶液500ml~ 1000ml内静脉滴注;
④上述处理后,收缩压仍低于80mmHg 时,可给升压药; ⑤支气管痉挛严重时,可静注0.25g氨茶碱;喉头水肿呼吸受
药物超敏反应综合征的诊断依据:
❖ 1.皮损 ❖ 2.血液学异常: 嗜酸性粒细胞≥1000/L或异
形淋巴细胞阳性。 ❖ 3.系统受累: 淋巴结肿大 直径≥2cm 肝炎、
间质性肾炎、间质性肺炎、心肌炎。 同时符合以上三条诊断标准的病例可确诊。
七、预防(prevetion)
(1)药物过敏史 (2)皮试: (3)合理用药 (4)停药 (5)禁忌卡
(drug-induced exfoliative dermatitis)
9.痤疮样药疹(acneiform ) 10.光感性药疹 (photosensitive drug eruption) 药物:多由于使用冬眠灵、磺胺类、四环素类、 灰黄霉素、补骨脂、喹诺酮类、吩噻嗪类及避 孕药等后经日光或紫外线照射而发病。 ①光毒反应性药疹
过量反应:如甲氨蝶吟治疗剂量与中毒剂量非 常接近,常可引起口腔溃疡、出血性皮损及白 细胞减少等。多见于老年人、肾功能不全者。
卡马西平致药物超敏反应综合征1例

卡马西平致药物超敏反应综合征1例吴军;王鲁妮【期刊名称】《中华老年多器官疾病杂志》【年(卷),期】2012(011)002【总页数】2页(P144-145)【关键词】卡马西平;药物超敏反应综合征【作者】吴军;王鲁妮【作者单位】广州军区广州总医院干部病房五科,广州 510010;广州军区广州总医院干部病房五科,广州 510010【正文语种】中文【中图分类】R971药物超敏反应综合征(drug-induced hypersensitivity syndrome, DIHS)是一种以急性广泛的皮损, 伴发热、淋巴结肿大、多脏器受累、嗜酸粒细胞增多及单核细胞增多等血液学异常为特征的严重全身性药物反应[1], 发病初期非皮肤专科医师容易误诊。
患者, 男, 60岁, 既往有过敏性鼻炎病史, 对酒精过敏。
入院前1个月因耳鸣而口服卡马西平片(得理多, 批号不详)100 mg, 2次/d, 曾出现双下肢一过性皮疹, 耳鸣减轻后停药, 皮疹消失, 未予重视。
入院前1周因耳鸣较前加重而再次口服卡马西平片(得理多, 批号不详)100 mg, 2次/d, 耳鸣症状无缓解, 故入院进一步治疗。
入院后继续口服卡马西平片(得理多, 批号X0487)100 mg, 2次/d, 入院第2天发现双下肢散在芝麻大小红斑, 并开始发热、寒战, 体温最高39.5℃, 无咳嗽、咳痰, 无咽喉疼痛, 无鼻塞流涕, 无腹痛、腹泻, 无尿频、尿急、尿痛。
心肺腹部查体及外周血常规均未见异常。
考虑病毒性感冒, 给予抗病毒及对症治疗。
入院第3天仍发热, 体温最高40℃, 面颊部、躯干及双下肢膝关节部位出现散在红色斑丘疹, 少数聚集成片, 无明显瘙痒, 考虑药物性皮疹, 立即停用卡马西平片, 给予口服抗过敏药物(西替利嗪、酮替芬、甲氰咪胍等)。
入院第4天仍发热, 体温最高39℃, 皮疹继续增多(头皮、面部、躯干及四肢红色斑丘疹较前明显密集并融合为成片, 无渗出及脱屑), 肝功能异常。
重组人粒细胞集落刺激因子注射液致严重不良反应

櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵櫵构的青霉素类抗菌药物;(3)必须使用青霉素类抗菌药物治疗而又过敏者,试行青霉素脱敏疗法。
其他抗菌药物致敏后,应结合其交叉过敏性,选择相对安全的抗菌药物治疗,尽量避免完全交叉过敏反应或部分交叉过敏的发生。
参考文献[1]刘桦,张佳丽.药物过敏反应的免疫学机制研究进展[J].中国现代应用药学杂志,2006,23(4):284-286,297.[2]刘小娟,王蓉蓉,蒋秋桃.药物诱导的速发型变态反应的研究进展[J].中国药事,2013,27(5):521-524.[3]Rajan TV.The Gell-Coombs classification of hypersensitivity reactions:a re-interpretation[J].Trends Immunol,2003,24(7):376-379.[4]LeoneR,Conforti A,Venegoni M,et al.Drug-induced anaphylaxis:case/non-case study based on an italian pharmacovigilance database[J].Drug Saf,2005,28(6):547-556.[5]Hari Y,Frutig-Schnyder K,Hurni M,et al.T cell involvement in cutaneous drug eruptions[J].Clin Exp Allergy,2001,31(9):1398-1408.[6]王欣春,吴文蓓.糖肽类抗生素致药物热二例[J].中国药物与临床,2011,11(10):1232.[7]杨晓,杨烨.喹诺酮类药物致过敏性休克165例文献分析[J].中国药房,2006,17(5):372-374.[8]张静艳.药物过敏反应与变态反应[J].中国麻醉与镇痛,2003,5(3):230-235.[9]孙春荣.药物过敏反应原因及护理对策[J].中国当代医药,*药师。
临床药师参与1_例左氧氟沙星致超敏反应的药学监护及文献分析

·药师与药学服务·临床药师参与1例左氧氟沙星致超敏反应的药学监护及文献分析Δ殷欢莉*,黄跃洲,罗敏,张臣宇,秦舟,唐文言,于磊 #(四川大学华西医院临床药学部,成都 610041)中图分类号 R 969.3 文献标志码 A 文章编号 1001-0408(2023)22-2805-05DOI 10.6039/j.issn.1001-0408.2023.22.21摘要 目的 分析左氧氟沙星致超敏反应的特点。
方法 临床药师参与1例左氧氟沙星致超敏反应患者的治疗过程,同时参考相关标准判断左氧氟沙星与超敏反应的关联性;检索中国知网、维普网、万方数据、PubMed 、Embase ,收集左氧氟沙星致超敏反应的相关文献并进行分析。
结果 临床药师针对患者发热、全身皮疹等症状,建议排查其既往用药史和过敏史,同时判断该超敏反应与左氧氟沙星的关联性为“可能”或“很可能”。
临床医师根据临床药师的判断,给予患者对症治疗。
该患者经治疗后好转。
文献分析结果显示,纳入的31例患者中,男性23例,女性8例,50岁及以上18例;24例患者的潜伏期为用药后4 d 及以内;不良反应主要为药物超敏反应综合征、固定性药疹、多形性红斑等;多数患者经停药和对症治疗后均好转。
结论 超敏反应为左氧氟沙星较罕见的不良反应,多发生于用药后2.5 h ~4 d ,以中老年男性患者的发生风险较高。
临床使用左氧氟沙星前应详细询问患者的药物过敏史,当其出现无明显诱因发热、皮疹时,应及时停药并对症处理,保证患者用药安全、有效。
关键词 左氧氟沙星;超敏反应;药学监护;文献分析Pharmaceutical care for one case of levofloxacin -induced hypersensitivity reaction by the participation of clinical pharmacists and literature analysis YIN Huanli ,HUANG Yuezhou ,LUO Min ,ZHANG Chenyu ,QIN Zhou ,TANG Wenyan ,YU Lei (Dept. of Clinical Pharmacy , West China Hospital of Sichuan University ,Chengdu 610041, China )ABSTRACT OBJECTIVE To analyze the characteristics of levofloxacin-induced hypersensitivity reaction. METHODS Clinical pharmacists participated in the treatment for a case of levofloxacin-induced hypersensitivity reaction , and adjudged the relationship of levofloxacin with hypersensitivity reaction according to relative standards. Retrieved from CNKI , VIP , Wanfang database , PubMed and Embase , relevant literature about levofloxacin-induced hypersensitivity reaction was collected and analyzed. RESULTS Clinical pharmacists suggested checking the patient ’s previous medication and allergy history based on symptoms such as fever and systemic rash , and determined that the drug hypersensitivity was “likely ” or “highly likely ” to be associated with levofloxacin. Clinicians provided symptomatic treatment to the patient based on the judgment of clinical pharmacists , and the patient improved after treatment. Results of the literature analysis showed that among 31 involved patients , there were 23 males and 8 females ; 18 patients aged 50 and above ; the incubation period of 24 patients was within 4 days after medication. The main adverse drug reactions were drug hypersensitivity syndrome , fixed drug eruption , erythema multiforme , etc. Most patients were improved after withdrawal and symptomatic treatment. CONCLUSIONS Hypersensitivity reaction is the rare adverse drug reaction of levofloxacin , mostly occurring within 2.5 h to 4 days after administration , and it is more likely to occur in middle-aged and elderly patients. Before clinical use , patients should be asked about their drug allergy history in detail ; when patients experience fever or rash without obvious causes , medication should be stopped promptly and symptomatic treatment should be taken to ensure the safety and effectiveness of the patients ’ medication.KEYWORDS levofloxacin ; hypersensitivity reaction ; pharmaceutical care ; literature analysis氟喹诺酮类药物因口服生物利用度高、分布容积大、抗菌谱广、不良反应发生率低、价格低廉等而被广泛应用于临床。
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
√
Myocarditis may develop at the beginning of the syndrome or up to 40 days after installation.Sym-ptoms include heart failure, chest pain, sudden tachycardia, dyspnea, and hypotension in early DRESS/DIHS.
accompanied by fever, lymphadenopathy, hepatitis, hematologic abnormalities with eosinophilia and atypical lymphocytes, and may involve other organs with eosinophilic infiltration, causing damage to several systems, especially to the kidneys, heart, lungs, and pancreas
Gene:NAT2 and certain human leukocyte antigen (HLA) alleles (immune response)
Clinical manifestations
incubation period(2-6weeks)
Fever,:often high (38.5-40oC)
Gastrointestinal bleeding may be an abrupt complication caused by ulcers caused by CMV
especially in cases related to advanced age, renal impairment, jaundice and hepatitis with reactivation of CMV. In contrast,cases where there is a reactivation of EpsteinBarr virus (EBV) seems to have less a severe course, but are more likely to have later development (usually after several years) of autoimmune diseases such as diabetes mellitus type 1 and autoimmune hypothyroidism
Auxiliary examination
Complete blood count, ALT, AST, total bilirrubin, GGT, alkaline phosphatase, sodium, potassium, creatinine and creatinine clearance, 24h urine protein and urinary eosinophil count, CPK, LDH, ferritin, triglycerides, calcium and PTH, blood glucose,TAP and TTPA, lipase,protein electrophoresis, creactive protein, quantitative PCR for HHV-6, 7, EBV and CMV, blood culture,anti-nuclear factor。
Drug-induced hypersensitivity syndrome (DIHS)
HISTORY
Drug-Induced Hypersensitivity Syndrome (DIHS), was first recognized in 1950 by Chaiken, in a patient using anticonvulsant.
Multiorgan involvement:myocarditis/myositis, pericarditis, interstitial nephritis (11% of cases),necrotizing granulomatous vasculitis in kidney, brain involvement (encephalitis or meningitis), colitis and thyroiditis.the mortality rate is about 10% to 20%,mainly died of severe hepatitis
Later,SaItzstein described this kind of drug reaction as pseudo lymphoma
In the 1960s with the development of carbamazepine, the disease named antispasmodic syndrome
is characterized by late onset, infectious mononucleosis-like symptoms, and herpesvirus 6 (HHV-6) reactivation.
Etiopathogenesis
Drug:deficiency or abnormality of the epoxide hydroxylase enzyme(环氧酶羟化酶) that detoxifies the metabolites of aromaticamine anticonvulsants (metabolic pathway)
→
Various hematologic abnormalities:Leukocytosis may be high, up until 11,000 leukocytes/mm3, and eosinophilia reaches values her than 1500/mm3
Hepatitis:hepatomegaly.ALT/AST increased.hepatic necrosis
Neurological complications include meningitis and encephalitis.occurs about 2 to 4 weeks after onset of the drug reaction
pulmonary involvement is rarely reported in DRESS/DIHS
Lymphadenopathy (>2mm)
The maculopapular eruption later becomes infiltrated with edematous follicular accentuat-ion.Swelling of the face, with marked periorbital involvement. Vesicles may arise and fine vesicles by edema of the dermis can be present.No necrosis of the epidermis like TEN occurs,except in rare cases of overlapping DRESS/DIHS andTEN. Small sterile perifollicular pustules and nonfollicular pustules may appear, which are different from acute generalized exanthematous pustulosis,and does not predominate on the main folds of the skin.. Over time the rash becomes purplish, sharply lower limbs andthe resolution is scaling. Another form of presentation is a picture of exfoliative dermatitis, which may be associated with mucosal involvement, such as cheilitis, erosions, pharygitis and enanthematous enlarged
Herpesvirus:associated sequential reactivation of herpesvirus family.(Recently,accumulating evidence suggests that other HHVs, such as HSV, EBV, HHV-7 and CMV might be reactivated during the course of DIHS)
Rash:Maculopapular rash developing> 3 weeks after starting therapy with a limited number of drugs.The cutaneous eruption consists of a morbilliform rash, which is also common in other less severe drug reactions and both presentations are indistinguishable The face, upper trunk and upper extremities are initially affected, with subsequent progression to the lower extremities.